Preceding local therapy to STRIDE for pretreated patients

Phase 2

Recruiting

• Conditions: Hepatocellular carcinoma

• Registration Number: JPRN-jRCT1041230013
• Lead Sponsor: Yamashita Tatsuya

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-04-22
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

1) clinically diagnosed as hepatocellular carcinoma
2) unsuitable for radical local therapy due to biloblar multiple nodules, ductal invasion, metastatic lesions, or other factors
3) previously treated by one or more systemic therapy
4) target lesion for paliative local therapy
5) preserved liver function
6) 18 years or older
7) ECOG Performance status <=2
8) preservation of major organ function
9) written informed consent

Exclusion Criteria

1) refractory ascites or pleural effusion
2) unsuitable for paliative local therapy
3) risky varices without prophylactic procedures
4) double cancer
5) metastases to central nervous system
6) severe complication
7) active infectious disease
8) pregnant or lactating women, or women of childbearing potential
9) mental disorder
10) patients who investigator regards as inappropriate for candidate

Study & Design

• Study Type: Interventional
• Study Design: Not specified